SINK COVID-19 study: Can common drugs offer 2-step approach to combat deadly virus?
Beaumont News Releases
04 May 2020
Researchers at Beaumont Hospital, Royal Oak have begun enrolling patients in a new clinical study aimed at treating COVID-19 patients with two common drugs – naltrexone and ketamine. It’s called SINK COVID-19, or the Study of Immunomodulation using Naltrexone and Ketamine for COVID-19.
Type of Video